Benzinga
Benzinga
Benzinga
giovedì, settembre 24

Inspire Medical Systems Inc

INSPNYSE
Trade with Public
Trade with Public
$69.20
0.140.21%
Ult. Agg.: Sep 24, 3:30 PM
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Inspire Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for Inspire Medical Systems (INSP).

Price Target Range — 9 Quarters

Analyst Consensus — 15 Analysts

6Buy
8Hold
1Sell
Consensus RatingNeutral# Analysts15Avg. Consensus PT$86Upside to Avg. PT+24.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Sep 21, 2026Freedom Capital MarketsKeith HintonPT RaiseBuy$71→$97
Sep 11, 2026StifelJonathan BlockPT RaiseBuy$75→$80
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.
Benzinga Newsdesk

PRO
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $75 to $80.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.
Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65

Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $55 to $65.
Benzinga Newsdesk

PRO
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.
Benzinga Newsdesk

PRO
Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62

Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved